AstraZeneca PLC
AstraZeneca Waste Data Preview
In 2024, AstraZeneca conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into AstraZeneca's Waste Treatment Practices
In 2024, AstraZeneca generated a total of 26,285 metric tonnes of waste.
Of this amount, 40.55% of AstraZeneca's total waste generated was recovered through methods such as recycling, reuse, or composting, while 5.09% was disposed of through landfilling, incineration, or combustion. The remaining 54.35% was either treated using unspecified methods or not clearly categorized.
AstraZeneca's Waste Recovery Rate
How much of AstraZeneca's waste is recycled or recovered?
In 2024, AstraZeneca reported a total waste generation of 26,285 metric tonnes, of which 40.55% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that AstraZeneca is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Has AstraZeneca reduced its environmental waste footprint over time?
Since 2021, AstraZeneca's total waste generation decreased by 4.97%, and remained stable in 2024, which may indicate a new baseline following earlier reductions in waste output.
Over the same period, AstraZeneca's waste recovery rate increased by 15.62%, but declined by 2.84% in 2024, potentially signaling volatility in waste treatment processes or shifting priorities in waste management.
Overall, AstraZeneca’s waste generation and recovery data show a mixed and inconsistent trend. A deeper analysis of the company's activities, industry benchmarks, and operational changes is needed to assess its sustainability performance more precisely.
AstraZeneca’s Waste Recovery vs. Disposal Over Time
- Total Waste Disposed
- Total Waste Recovered
Insights into AstraZeneca’s Generation of Hazardous and Non-Hazardous Waste
In 2024, AstraZeneca generated a total of 26,285 metric tonnes of waste.
Of this amount, 37.01% of AstraZeneca's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 62.99% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
AstraZeneca’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How AstraZeneca reduced the environmental impact of its waste?
Since 2021, AstraZeneca's total waste generation decreased by 4.97%, and remained stable in 2024, signaling a plateau following previous reductions that may mark a new waste baseline.
Over the same period, the share of hazardous waste increased by 2.05%, while holding steady in 2024, pointing to potential stagnation in efforts to reduce harmful waste types after a period of worsening performance.
Overall, AstraZeneca's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
How does AstraZeneca treat its hazardous waste?
In 2024, AstraZeneca reported that 9,728 metric tonnes of its total waste output were classified as hazardous. This represents 37.01% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Approximately 10.71% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.